in this issue
Regions :: India/Pakistan
Johnson Matthey catalysis and chiral technologies business expands capacity
12:19 AM MDT | August 14, 2013 | Deepti Ramesh
Johnson Matthey says its Johnson Matthey Catalysis and Chiral Technologies (JMCCT) business unit, which provides heterogeneous, homogeneous, chiral and biocatalytic technologies for customers in the pharmaceutical, fine chemical and agrochemical industries, is expanding its specialty ligand manufacturing capability to include commercial-scale manufacturing up to 100 kilograms. The company has a diverse specialty ligands portfolio, and this expansion is largely focused on the Buchwald ligands from the Massachusetts Institute of Technology, Johnson Matthey says...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee